SHANDONG BOAN BIOTECH.H 1 (UJ9) — Financial Flexibility Index
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Financial Flexibility Index of 0.24x as of December 2025. Free cash flow of €338.94 Million (operating CF €64.89 Million minus capex €274.05 Million) represents 0% of total liabilities (€1.39 Billion). Also explore UJ9 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SHANDONG BOAN BIOTECH.H 1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SHANDONG BOAN BIOTECH.H 1 across 5 annual periods. Check UJ9 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SHANDONG BOAN BIOTECH.H 1 (2021–2025)
Year-by-year free cash flow to debt coverage for SHANDONG BOAN BIOTECH.H 1. For the full company profile including market capitalisation, see UJ9 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | €338.94 Million | €64.89 Million | €1.39 Billion | ▲ +20.5% |
| 2024 | 0.20x | €244.97 Million | €-117.94 Million | €1.21 Billion | ▼ -26.3% |
| 2023 | 0.28x | €276.19 Million | €-18.57 Million | €1.00 Billion | ▲ +4659.1% |
| 2022 | 0.01x | €4.54 Million | €-201.84 Million | €784.18 Million | ▼ -96.6% |
| 2021 | 0.17x | €94.97 Million | €-246.28 Million | €554.92 Million | — |